JAMP OSELTAMIVIR
Identification of Jamp Oseltamivir
| No description |
Google image searchProduct monograph
Active ingredient
oseltamivir (oseltamivir phosphate), 30 MG
DIN: 02497409
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 24-SEP-2020
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AH — Neuraminidase inhibitors (ATC, ATC/DDD)
- J05AH02 — OSELTAMIVIR (ATC/DDD)
Reference brand drug: Tamiflu
Pharmaceutical standard: USP
